These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 21804086

  • 1. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
    Buchholz B, Klanke B, Schley G, Bollag G, Tsai J, Kroening S, Yoshihara D, Wallace DP, Kraenzlin B, Gretz N, Hirth P, Eckardt KU, Bernhardt WM.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
    Yamaguchi T, Reif GA, Calvet JP, Wallace DP.
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.
    Ravichandran K, Zafar I, Ozkok A, Edelstein CL.
    Nephrol Dial Transplant; 2015 Jan; 30(1):45-53. PubMed ID: 25239638
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion.
    Nantavishit J, Chatsudthipong V, Soodvilai S.
    Biochem Pharmacol; 2018 Aug; 154():175-182. PubMed ID: 29746821
    [Abstract] [Full Text] [Related]

  • 11. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV, Zhou JX, Magenheimer BS, Reif GA, Wallace DP, Georg GI, Jakkaraj SR, Tash JS, Yu ASL, Li X, Calvet JP.
    Am J Physiol Renal Physiol; 2022 Oct 01; 323(4):F492-F506. PubMed ID: 35979967
    [Abstract] [Full Text] [Related]

  • 12. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP.
    J Am Soc Nephrol; 2006 Jan 01; 17(1):178-87. PubMed ID: 16319189
    [Abstract] [Full Text] [Related]

  • 13. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Chandra AN, Saravanabavan S, Rangan GK.
    Int J Mol Sci; 2021 Sep 29; 22(19):. PubMed ID: 34638853
    [Abstract] [Full Text] [Related]

  • 14. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
    Dwivedi N, Jamadar A, Mathew S, Fields TA, Rao R.
    Kidney Int; 2023 Jan 29; 103(1):144-155. PubMed ID: 36273656
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
    Tonum K, Srimai N, Chabang N, Fongsupa S, Tuchinda P, Torres JA, Weimbs T, Soodvilai S.
    Int J Mol Sci; 2022 Apr 14; 23(8):. PubMed ID: 35457146
    [Abstract] [Full Text] [Related]

  • 16. Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat.
    Nagao S, Nishii K, Yoshihara D, Kurahashi H, Nagaoka K, Yamashita T, Takahashi H, Yamaguchi T, Calvet JP, Wallace DP.
    Kidney Int; 2008 Feb 14; 73(3):269-77. PubMed ID: 17943077
    [Abstract] [Full Text] [Related]

  • 17. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
    Zhu Y, Teng T, Wang H, Guo H, Du L, Yang B, Yin X, Sun Y.
    Food Funct; 2018 Jan 24; 9(1):389-396. PubMed ID: 29215110
    [Abstract] [Full Text] [Related]

  • 18. Diverse Receptor Tyrosine Kinase Phosphorylation in Urine-Derived Tubular Epithelial Cells from Autosomal Dominant Polycystic Kidney Disease Patients.
    Ikeda K, Kusaba T, Tomita A, Watanabe-Uehara N, Ida T, Kitani T, Yamashita N, Uehara M, Matoba S, Yamada T, Tamagaki K.
    Nephron; 2020 Jan 24; 144(10):525-536. PubMed ID: 32799196
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y, Inagi R, Yoshihara D, Kugita M, Nagao S, Shimizu A, Takeda N, Wake M, Honda K, Zhou J, Nangaku M.
    Mol Cell Biol; 2017 Dec 15; 37(24):. PubMed ID: 28993480
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, Wüthrich RP.
    Nephrol Dial Transplant; 2006 Mar 15; 21(3):598-604. PubMed ID: 16221708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.